HIV Seroprevalence

Edit My Profile

"HIV Seroprevalence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY).

Descriptor ID	D015528
MeSH Number(s)	E05.318.760.500.950.375 N05.715.360.775.175.800.375 N06.850.520.450.500.950.375
Concept/Terms	HIV Seroprevalence HIV Seroprevalence Seroprevalence, HIV

Below are MeSH descriptors whose meaning is more general than "HIV Seroprevalence".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Epidemiologic Study Characteristics [E05.318.760]
Epidemiologic Studies [E05.318.760.500]
Seroepidemiologic Studies [E05.318.760.500.950]
HIV Seroprevalence [E05.318.760.500.950.375]
Health Care [N]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Epidemiologic Study Characteristics [N05.715.360.775]
Epidemiologic Studies [N05.715.360.775.175]
Seroepidemiologic Studies [N05.715.360.775.175.800]
HIV Seroprevalence [N05.715.360.775.175.800.375]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Epidemiologic Study Characteristics [N06.850.520.450]
Epidemiologic Studies [N06.850.520.450.500]
Seroepidemiologic Studies [N06.850.520.450.500.950]
HIV Seroprevalence [N06.850.520.450.500.950.375]

Below are MeSH descriptors whose meaning is related to "HIV Seroprevalence".

Below are MeSH descriptors whose meaning is more specific than "HIV Seroprevalence".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HIV Seroprevalence" by people in this website by year, and whether "HIV Seroprevalence" was a major or minor topic of these publications.

Bar chart showing 3 publications over 3 distinct years, with a maximum of 1 publications in 1995 and 1996 and 1997

To see the data from this visualization as text, click here.

Year	Major Topic	Total
1995	1	1
1996	1	1
1997	1	1

Below are the most recent publications written about "HIV Seroprevalence" by people in Profiles.

Haley DF, Lucas J, Golin CE, Wang J, Hughes JP, Emel L, El-Sadr W, Frew PM, Justman J, Adimora AA, Watson CC, Mannheimer S, Rompalo A, Soto-Torres L, Tims-Cook Z, Carter Y, Hodder SL. Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064). AIDS Patient Care STDS. 2014 Apr; 28(4):206-17.

View in: PubMed
Stefan MS, Blackwell JM, Crawford KM, Martinez J, Wu Sung S, Holliday SA, Landry M, Lavine N, Lerfald N, Morris JL, Greene S, Cykert S. Patients' attitudes toward and factors predictive of human immunodeficiency virus testing of academic medical clinics. Am J Med Sci. 2010 Oct; 340(4):264-7.

View in: PubMed
Canosa CA, Grady GF, Cabello ML, Comeau AM, Schwerzler ME, Contreras MT, Fraga JM, Gomez de los Terreros I, Pena J. Anonymous testing of newborn infants for HIV antibodies as a basis for estimating prevalence of HIV in childbearing women: the 1991-1994 study in Spain. Acta Paediatr Suppl. 1997 Jun; 421:67-71.

View in: PubMed
Orr MF, Glebatis D, Friedmann P, des Jarlais DC, Prevots DR. Incidence of HIV infection in a New York City methadone maintenance treatment program. JAMA. 1996 Jul 10; 276(2):99.

View in: PubMed
Des Jarlais DC, Hagan H, Friedman SR, Friedmann P, Goldberg D, Frischer M, Green S, Tunving K, Ljungberg B, Wodak A, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1995 Oct 18; 274(15):1226-31.

View in: PubMed
Grady GF. HIV mass screening of infants and mothers: historical, technical, and practical issues. Acta Paediatr Suppl. 1994 Aug; 400:39-42.

View in: PubMed
Hsu HW, Moye J, Kunches L, Ng P, Shea B, Caldwell B, Demaria A, Mofenson L, Grady GF. Perinatally acquired human immunodeficiency virus infection: extent of clinical recognition in a population-based cohort. Massachusetts Pediatric HIV Surveillance Working Group. Pediatr Infect Dis J. 1992 Nov; 11(11):941-5.

View in: PubMed
Donegan SP, Steger KA, Recla L, Hoff RS, Werner BG, Rice PA, Craven DE. Seroprevalence of human immunodeficiency virus in parturients at Boston City Hospital: implications for public health and obstetric practice. Am J Obstet Gynecol. 1992 Sep; 167(3):622-9.

View in: PubMed
Janssen RS, St Louis ME, Satten GA, Critchley SE, Petersen LR, Stafford RS, Ward JW, Hanson DL, Olivo N, Schable CA, et al. HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group. N Engl J Med. 1992 Aug 13; 327(7):445-52.

View in: PubMed
Choopanya K, Vanichseni S, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, Friedmann P, Friedman SR. Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS. 1991 Dec; 5(12):1509-13.

View in: PubMed

People

Explore

Similar Concepts

Top Journals